DIA: Experts call for more clarity on reporting requirements in FDA’s DCT guidance
Regulatory NewsJoanne S. Eglovitch
Clinical TrialsComplianceMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyResearch, Design and DevelopmentRegulatory NewsJoanne S. EglovitchClinical TrialsComplianceMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyResearch, Design and Development